ES492143A0 - Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina - Google Patents

Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina

Info

Publication number
ES492143A0
ES492143A0 ES492143A ES492143A ES492143A0 ES 492143 A0 ES492143 A0 ES 492143A0 ES 492143 A ES492143 A ES 492143A ES 492143 A ES492143 A ES 492143A ES 492143 A0 ES492143 A0 ES 492143A0
Authority
ES
Spain
Prior art keywords
compounds
trihi
droxipiperidina
derivatives
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES492143A
Other languages
English (en)
Other versions
ES8102096A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES492143A0 publication Critical patent/ES492143A0/es
Publication of ES8102096A1 publication Critical patent/ES8102096A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fodder In General (AREA)
ES492143A 1979-06-05 1980-06-04 Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina Expired ES8102096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792922760 DE2922760A1 (de) 1979-06-05 1979-06-05 Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung

Publications (2)

Publication Number Publication Date
ES492143A0 true ES492143A0 (es) 1980-12-16
ES8102096A1 ES8102096A1 (es) 1980-12-16

Family

ID=6072499

Family Applications (1)

Application Number Title Priority Date Filing Date
ES492143A Expired ES8102096A1 (es) 1979-06-05 1980-06-04 Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina

Country Status (18)

Country Link
US (1) US4465684A (es)
EP (1) EP0019899B1 (es)
JP (1) JPS55164676A (es)
AT (1) ATE8500T1 (es)
AU (1) AU539847B2 (es)
CA (1) CA1146558A (es)
DE (2) DE2922760A1 (es)
DK (1) DK243280A (es)
ES (1) ES8102096A1 (es)
FI (1) FI801787A7 (es)
GR (1) GR69267B (es)
HU (1) HU182143B (es)
IE (1) IE50258B1 (es)
IL (1) IL60210A (es)
NO (2) NO801553L (es)
PT (1) PT71308A (es)
SU (2) SU1017168A3 (es)
ZA (1) ZA803330B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative
JPH03500256A (ja) * 1987-11-16 1991-01-24 メデイコープ　ホールディング　ソシエテ　アノニム 液体物質の分散装置
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
DE3936295A1 (de) * 1989-11-01 1991-05-02 Bayer Ag Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
JPH0688963B2 (ja) * 1990-08-15 1994-11-09 工業技術院長 ジ（フェニル）スルホンスルホニルフルオライド化合物
AUPP942599A0 (en) * 1999-03-24 1999-04-15 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
EP1575587A1 (en) * 2002-10-29 2005-09-21 Ranbaxy Laboratories, Ltd. Iminosugar derivatives as glucosidase inhibitors
US20250197372A1 (en) * 2020-07-10 2025-06-19 Emergent Product Development Gaithersburg Inc. Deoxynojirimycin derivatives as glucosidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative

Also Published As

Publication number Publication date
EP0019899A1 (de) 1980-12-10
NO852778L (no) 1980-12-08
IL60210A (en) 1983-11-30
ATE8500T1 (de) 1984-08-15
SU1017168A3 (ru) 1983-05-07
NO801553L (no) 1980-12-08
DE2922760A1 (de) 1980-12-11
FI801787A7 (fi) 1981-01-01
IE801149L (en) 1980-12-05
HU182143B (en) 1983-12-28
JPS64949B2 (es) 1989-01-10
GR69267B (es) 1982-05-12
ZA803330B (en) 1981-06-24
JPS55164676A (en) 1980-12-22
IL60210A0 (en) 1980-09-16
EP0019899B1 (de) 1984-07-18
US4465684A (en) 1984-08-14
PT71308A (en) 1980-06-01
CA1146558A (en) 1983-05-17
IE50258B1 (en) 1986-03-19
SU1050563A3 (ru) 1983-10-23
ES8102096A1 (es) 1980-12-16
AU539847B2 (en) 1984-10-18
AU5852580A (en) 1980-12-11
DK243280A (da) 1980-12-06
DE3068585D1 (en) 1984-08-23

Similar Documents

Publication Publication Date Title
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
DK173883D0 (da) Substituerede 8-phenylxanthiner
ES521422A0 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
IL58775A (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
ES499782A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
ES492821A0 (es) Procedimiento para la obtencion de derivados de 2-hidroxime-til-3,4,5-trihidroxipiperidinas
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
ES519690A0 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
ES492537A0 (es) Procedimiento para la obtencion de pseudo-trisacaridos
DE3262124D1 (en) Saturated derivatives of aminocyclitols, their preparation and pharmaceutical preparations containing them
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
ES488301A0 (es) Procedimiento para la obtencion de dehidropeptidos
ES488709A0 (es) Procedimiento para la preparacion de compuestos diorganomag-nesicos,r2mg
ATE3033T1 (de) Derivate des 2-hydroxymethyl-3,4,5-trihydroxypiperidins, ihre herstellung und sie enthaltende arzneimittel.
ES489822A0 (es) Procedimiento para la obtencion de 3-sulfonil-benzo-1,2-4- triazinas y benzo-1,2-4-triazin-1-oxidos
MX6121E (es) Procedimiento para la preparacion de derivados de 3,4-cicloalquil triazoles

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603